NDC 63629-1349 is a in the category. It is labeled and distributed by .
| Proprietary Name | NDC 63629-1349 |
| Marketing Category | / |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2010-11-24 |
| Marketing End Date | 2017-12-31 |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2007-05-24 |
| Marketing End Date | 2017-12-31 |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2010-11-24 |
| Marketing End Date | 2017-12-31 |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2007-05-24 |
| Marketing End Date | 2017-12-31 |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2010-11-24 |
| Marketing End Date | 2017-12-31 |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2007-05-24 |
| Marketing End Date | 2017-12-31 |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2010-11-24 |
| Marketing End Date | 2017-12-31 |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2010-11-24 |
| Marketing End Date | 2017-12-31 |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2007-05-24 |
| Marketing End Date | 2017-12-31 |